BNP PARIBAS FINANCIAL MARKETS - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 195 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$695,881
+104.9%
89,560
+155.3%
0.00%
Q2 2023$339,603
-44.5%
35,083
-37.2%
0.00%
-100.0%
Q1 2023$612,028
+331.1%
55,842
+69.9%
0.00%
Q4 2022$141,981
-100.0%
32,866
-49.0%
0.00%
-100.0%
Q3 2022$484,296,000
+58.9%
64,401
+112.4%
0.00%
Q2 2022$304,746,000
-56.3%
30,323
-46.2%
0.00%
-100.0%
Q1 2022$697,378,000
+29500.1%
56,331
+54590.3%
0.00%
Q4 2021$2,356,000
-94.1%
103
-94.3%
0.00%
Q3 2021$39,679,0001,7930.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders